BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 16824542)

  • 1. Structural basis for phosphotyrosine recognition by the Src homology-2 domains of the adapter proteins SH2-B and APS.
    Hu J; Hubbard SR
    J Mol Biol; 2006 Aug; 361(1):69-79. PubMed ID: 16824542
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adapter protein with a pleckstrin homology (PH) and an Src homology 2 (SH2) domain (APS) and SH2-B enhance insulin-receptor autophosphorylation, extracellular-signal-regulated kinase and phosphoinositide 3-kinase-dependent signalling.
    Ahmed Z; Pillay TS
    Biochem J; 2003 Apr; 371(Pt 2):405-12. PubMed ID: 12521378
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dissection of the energetic coupling across the Src SH2 domain-tyrosyl phosphopeptide interface.
    Lubman OY; Waksman G
    J Mol Biol; 2002 Feb; 316(2):291-304. PubMed ID: 11851339
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alternative mode of binding to phosphotyrosyl peptides by Src homology-2 domains.
    Qin C; Wavreille AS; Pei D
    Biochemistry; 2005 Sep; 44(36):12196-202. PubMed ID: 16142918
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Investigation of phosphotyrosine recognition by the SH2 domain of the Src kinase.
    Bradshaw JM; Mitaxov V; Waksman G
    J Mol Biol; 1999 Nov; 293(4):971-85. PubMed ID: 10543978
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutational investigation of the specificity determining region of the Src SH2 domain.
    Bradshaw JM; Mitaxov V; Waksman G
    J Mol Biol; 2000 Jun; 299(2):521-35. PubMed ID: 10860756
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibitory effects of rosmarinic acid on Lck SH2 domain binding to a synthetic phosphopeptide.
    Ahn SC; Oh WK; Kim BY; Kang DO; Kim MS; Heo GY; Ahn JS
    Planta Med; 2003 Jul; 69(7):642-6. PubMed ID: 12898421
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Probing the "two-pronged plug two-holed socket" model for the mechanism of binding of the Src SH2 domain to phosphotyrosyl peptides: a thermodynamic study.
    Bradshaw JM; Grucza RA; Ladbury JE; Waksman G
    Biochemistry; 1998 Jun; 37(25):9083-90. PubMed ID: 9636054
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Solution structure of the human Grb14-SH2 domain and comparison with the structures of the human Grb7-SH2/erbB2 peptide complex and human Grb10-SH2 domain.
    Scharf PJ; Witney J; Daly R; Lyons BA
    Protein Sci; 2004 Sep; 13(9):2541-6. PubMed ID: 15322292
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The N-terminal SH2 domain of the tyrosine phosphatase, SHP-2, is essential for Jak2-dependent signaling via the angiotensin II type AT1 receptor.
    Godeny MD; Sayyah J; VonDerLinden D; Johns M; Ostrov DA; Caldwell-Busby J; Sayeski PP
    Cell Signal; 2007 Mar; 19(3):600-9. PubMed ID: 17027227
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin increase in MAP kinase phosphorylation is shifted to early time-points by overexpressing APS, while Akt phosphorylation is not influenced.
    Onnockx S; Xie J; Degraef C; Erneux C; Pirson I
    Exp Cell Res; 2009 Sep; 315(15):2479-86. PubMed ID: 19527711
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Crystal structures of the human p56lck SH2 domain in complex with two short phosphotyrosyl peptides at 1.0 A and 1.8 A resolution.
    Tong L; Warren TC; King J; Betageri R; Rose J; Jakes S
    J Mol Biol; 1996 Mar; 256(3):601-10. PubMed ID: 8604142
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Crystal structure of the C-terminal SH2 domain of the p85alpha regulatory subunit of phosphoinositide 3-kinase: an SH2 domain mimicking its own substrate.
    Hoedemaeker FJ; Siegal G; Roe SM; Driscoll PC; Abrahams JP
    J Mol Biol; 1999 Oct; 292(4):763-70. PubMed ID: 10525402
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Simultaneous assay of Src SH3 and SH2 domain binding using different wavelength fluorescence polarization probes.
    Lynch BA; Minor C; Loiacono KA; van Schravendijk MR; Ram MK; Sundaramoorthi R; Adams SE; Phillips T; Holt D; Rickles RJ; MacNeil IA
    Anal Biochem; 1999 Nov; 275(1):62-73. PubMed ID: 10542110
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural basis for the high affinity of amino-aromatic SH2 phosphopeptide ligands.
    Rahuel J; García-Echeverría C; Furet P; Strauss A; Caravatti G; Fretz H; Schoepfer J; Gay B
    J Mol Biol; 1998 Jun; 279(4):1013-22. PubMed ID: 9642078
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural characterization of a novel Cbl phosphotyrosine recognition motif in the APS family of adapter proteins.
    Hu J; Hubbard SR
    J Biol Chem; 2005 May; 280(19):18943-9. PubMed ID: 15737992
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SH2 and PTB domains in tyrosine kinase signaling.
    Schlessinger J; Lemmon MA
    Sci STKE; 2003 Jul; 2003(191):RE12. PubMed ID: 12865499
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The p95-100 kDa ligand of the T cell-specific adaptor (TSAd) protein Src-homology-2 (SH2) domain implicated in TSAd nuclear import is p97 Valosin-containing protein (VCP).
    Marti F; King PD
    Immunol Lett; 2005 Mar; 97(2):235-43. PubMed ID: 15752563
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kinase activation through dimerization by human SH2-B.
    Nishi M; Werner ED; Oh BC; Frantz JD; Dhe-Paganon S; Hansen L; Lee J; Shoelson SE
    Mol Cell Biol; 2005 Apr; 25(7):2607-21. PubMed ID: 15767667
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Binding of SH2-B family members within a potential negative regulatory region maintains JAK2 in an active state.
    Kurzer JH; Saharinen P; Silvennoinen O; Carter-Su C
    Mol Cell Biol; 2006 Sep; 26(17):6381-94. PubMed ID: 16914724
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.